Depression is a unipolar condition caused by a brain monoamine deficit that affects emotion, thinking, and function. Depression treatments involve limitations such poor absorption, a delay in therapeutic efficacy, unwanted side effects, and high-dose toxicity. A simple, affordable, clean, non-toxic, and environmentally friendly nanoparticle manufacturing method was used to fix this. This research created C.sativus gold nanoparticles (CS-AuNPs) from Crocus sativus extract and auric chloride (HAuCl4). CS-AuNPs was spherical, 11–20 nm in size, and 550 nm absorbent after UV–vis, XRD, FTIR, SEM, and TEM analysis. Saffron action is increased using gold nanoparticles, a non-toxic drug delivery vehicle. Crocins, crocetin, and safranal are important antidepressants. Crocus sativus has been shown to effectively reduce proinflammatory cytokines mRNA expression (IL-1β, IL-6, and TNF-α) and inhibit NF-κB activation. With an IC50 of 256 μg/ml for DPPH, IC50 of 300 μg/ml for NBT assay and 90 % cell survival in cytotoxicity tests, this chemical is safe and effective as an antidepressant. The new study showed that C.sativus has therapeutic promise and that converting it from extract to nanoparticles will benefit depression treatment.